Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
15.79
-1.52 (-8.78%)
At close: Apr 1, 2025, 4:00 PM
16.00
+0.21 (1.32%)
After-hours: Apr 1, 2025, 5:31 PM EDT

Structure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-122.53-89.62-51.32-38.05-15.88
Depreciation & Amortization
10.320.280.07-
Other Amortization
---0.050.02
Loss (Gain) From Sale of Investments
-18.47-5.98-0.910.030.03
Stock-Based Compensation
18.798.192.511.490.57
Other Operating Activities
1.60.630.350.190.02
Change in Accounts Payable
3.31-0.862.151.91.02
Change in Other Net Operating Assets
-0.347.830.822.17-0.07
Operating Cash Flow
-116.64-79.49-46.12-32.16-14.28
Capital Expenditures
-1.29-2.17-0.16-1.21-0.02
Investment in Securities
-357.62-266.18-61.9519.07-21.13
Investing Cash Flow
-358.91-268.34-62.1117.86-21.15
Issuance of Common Stock
517.06473.10.030.01-
Repurchase of Common Stock
---0.01--
Other Financing Activities
-1.8-21.57-2.513.24-0.16
Financing Cash Flow
515.26451.5329.01103.2525.84
Net Cash Flow
39.72103.7-79.2188.95-9.59
Free Cash Flow
-117.93-81.66-46.28-33.37-14.3
Free Cash Flow Per Share
-2.24-2.22-14.48-12.30-6.85
Levered Free Cash Flow
-70.78-51.38-26.08-18.79-
Unlevered Free Cash Flow
-70.78-51.38-26.08-18.76-
Change in Net Working Capital
-9.62-6.51-4.14-4.45-
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q